第一单位：
Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
作者：
James D,Phelan [1]
;
Ryan M,Young [1]
;
Daniel E,Webster [1]
;
Sandrine,Roulland [2]
;
George W,Wright [3]
;
Monica,Kasbekar [1]
;
Arthur L,Shaffer [1]
;
Michele,Ceribelli [4]
;
James Q,Wang [1]
;
Roland,Schmitz [1]
;
Masao,Nakagawa [1]
;
Emmanuel,Bachy [1]
;
Da Wei,Huang [1]
;
Yanlong,Ji [5]
;
Lu,Chen [4]
;
Yandan,Yang [1]
;
Hong,Zhao [1]
;
Xin,Yu [1]
;
Weihong,Xu [1]
;
Maryknoll M,Palisoc [6]
;
Racquel R,Valadez [6]
;
Theresa,Davies-Hill [6]
;
Wyndham H,Wilson [1]
;
Wing C,Chan [7]
;
Elaine S,Jaffe [6]
;
Randy D,Gascoyne [8]
;
Elias,Campo [9]
;
Andreas,Rosenwald [10]
;
German,Ott [11]
;
Jan,Delabie [12]
;
Lisa M,Rimsza [13]
;
Fausto J,Rodriguez [14]
;
Fayez,Estephan [15]
;
Matthias,Holdhoff [15]
;
Michael J,Kruhlak [16]
;
Stephen M,Hewitt [17]
;
Craig J,Thomas [18]
;
Stefania,Pittaluga [6]
;
Thomas,Oellerich [19]
;
Louis M,Staudt [20]
作者单位：
Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
[1]
Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.;Aix-Marseille University, CNRS, INSERM, Centre d'Immunologie de Marseille-Luminy, Marseille, France.
[2]
Biometric Research Branch, Division of Cancer Diagnosis and Treatment, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
[3]
Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Gaithersburg, MD, USA.
[4]
Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt, Germany.
[5]
Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
[6]
Departments of Pathology, City of Hope National Medical Center, Duarte, CA, USA.
[7]
British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
[8]
Hospital Clinic, University of Barcelona, Barcelona, Spain.
[9]
Institute of Pathology, University of Würzburg, and Comprehensive Cancer Center Mainfranken, Würzburg, Germany.
[10]
Department of Clinical Pathology, Robert-Bosch-Krankenhaus, and Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology, Stuttgart, Germany.
[11]
University Health Network, Laboratory Medicine Program, Toronto General Hospital and University of Toronto, Toronto, Ontario, Canada.
[12]
Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ, USA.
[13]
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
[14]
Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
[15]
Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
[16]
Experimental Pathology Laboratory, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
[17]
Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.;Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Gaithersburg, MD, USA.
[18]
Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. thomas.oellerich@kgu.de.;Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt, Germany. thomas.oellerich@kgu.de.;German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany. thomas.oellerich@kgu.de.
[19]
Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. lstaudt@mail.nih.gov.
[20]
医学主题词
腺嘌呤(Adenine);动物(Animals);活组织检查(Biopsy);药物设计(Drug Design);女(雌)性(Female);人类(Humans);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);小鼠(Mice);多蛋白复合物(Multiprotein Complexes);突变(Mutation);髓样分化因子88(Myeloid Differentiation Factor 88);NF-κB(NF-kappa B);哌啶类(Piperidines);蛋白质组学(Proteomics);吡唑类(Pyrazoles);嘧啶类(Pyrimidines);受体, 抗原, B细胞(Receptors, Antigen, B-Cell);信号传导(Signal Transduction);TOR丝氨酸-苏氨酸激酶(TOR Serine-Threonine Kinases);Toll样受体9(Toll-Like Receptor 9);肿瘤细胞, 培养的(Tumor Cells, Cultured);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1038/s41586-018-0290-0
PMID
29925955
发布时间
2025-05-30
换一批
